What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink

BACKGROUND: Drugs for dementia have been available in England since 1997. Since their launch, there have been several changes to national guidelines and initiatives that may have influenced prescribing. These include changes in National Institute for Health and Care Excellence (NICE) guidance, sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Venexia M., Davies, Neil M., Kehoe, Patrick G., Martin, Richard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975499/
https://www.ncbi.nlm.nih.gov/pubmed/29843807
http://dx.doi.org/10.1186/s13195-018-0379-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975499/
https://www.ncbi.nlm.nih.gov/pubmed/29843807
http://dx.doi.org/10.1186/s13195-018-0379-6

Ejemplares similares